Reynolds Capital Management’s AbbVie ABBV Stock Holding History

Reynolds Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-5,600	Closed	-$332K	–	111
2015 Q4	$332K	Buy	+5,600	New	+$323K	0.36%	87
2015 Q3	–	Sell	-6,200	Closed	-$417K	–	133
2015 Q2	$417K	Buy	6,200 +1,500	+32%	+$97.9K	0.41%	85
2015 Q1	$275K	Sell	4,700 -1,100	-19%	-$66.5K	0.24%	162
2014 Q4	$380K	Buy	+5,800	New	+$366K	0.32%	121
2014 Q3	–	Sell	-4,100	Closed	-$231K	–	212
2014 Q2	$231K	Sell	4,100 -200	-5%	-$10.5K	0.16%	282
2014 Q1	$221K	Sell	4,300 -1,000	-19%	-$50.5K	0.14%	318
2013 Q4	$280K	Buy	+5,300	New	+$260K	0.16%	256
2013 Q3	–	Sell	-5,600	Closed	-$232K	–	422
2013 Q2	$232K	Buy	+5,600	New	+$245K	0.17%	269

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Reynolds Capital Management's ABBV Position: Q1 2016 in Review

Reynolds Capital Management sold out of AbbVie (ABBV) in Q1 2016, closing a stake of 5,600 shares — an estimated $332K sold.

Reynolds Capital Management first reported a position in ABBV in Q2 2013 and held it in 8 quarters. The position peaked at $417K in Q2 2015. 1,639 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

Reynolds Capital Management reported no remaining AbbVie position as of Q1 2016 after selling out during the quarter.
Reynolds Capital Management sold 5,600 AbbVie shares in Q1 2016, an estimated $332K.
Reynolds Capital Management first reported a position in AbbVie in Q2 2013 and held it in 8 quarters.
Reynolds Capital Management's AbbVie position peaked at $417K in Q2 2015.
1,639 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Reynolds Capital Management's 13F filing for Q1 2016, filed 13 May 2016.